Endo Announces Execution of Definitive Settlement Agreement and Release Resolving Tennessee State Court Case
DUBLIN, Aug. 4, 2021 /PRNewswire/ --Endo Internationalplc(NASDAQ: ENDP) today announced that its wholly-owned subsidiariesEndo Health Solutions Inc.andEndo Pharmaceuticals Inc.(collectively, "Endo") have executed a definitive Settlement Agreement and Release (the "Settlement Agreement") resolving an opioid-related case originally captioned asStaubus, et al.
- DUBLIN, Aug. 4, 2021 /PRNewswire/ --Endo Internationalplc(NASDAQ: ENDP) today announced that its wholly-owned subsidiariesEndo Health Solutions Inc.andEndo Pharmaceuticals Inc.(collectively, "Endo") have executed a definitive Settlement Agreement and Release (the "Settlement Agreement") resolving an opioid-related case originally captioned asStaubus, et al.
- The Staubus case involved claims by nine counties in eastern Tennessee, eighteen cities and towns within those counties and one individual plaintiff.
- The settlement includes no admission of wrongdoing, fault or liability of any kind by Endo, and the settlement value should not be extrapolated to any other opioid-related cases or claims.
- All forward-looking statements in this press release reflectEndo'scurrent expectations of future events based on information available toEndoas of the date of this press release.